Real Brokerage (REAX) files Rule 144 notice to sell 200,000 common shares

Rhea-AI Filing Summary

Real Brokerage (REAX) submitted a Form 144 notice reporting a proposed Rule 144 sale of 200,000 common shares through J.P. Morgan Securities LLC. The filing lists an aggregate market value of $788,000 and shares outstanding of 202,499,045, with an approximate sale date of 08/11/2025.

The securities were acquired on 06/05/2020 in a private investment from the issuer, totaling 200,000 shares paid in cash. The filer reports no securities sold in the past three months and makes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Rule 144 notice filed, indicating the proposed sale is being disclosed in accordance with securities regulations
• Broker disclosed as J.P. Morgan Securities LLC, providing an established execution channel for the transaction

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 filing for a small, disclosed sale; likely neutral for REAX share supply and market impact.

The Form 144 notifies a proposed sale of 200,000 common shares with an aggregate market value of $788,000, to be executed via J.P. Morgan Securities LLC. Given the shares outstanding of 202,499,045, the position is a small portion of the float. The filing shows the securities were acquired in a private investment on 06/05/2020 and paid in cash. No sales in the past three months are reported, indicating this is a discrete, disclosed transaction rather than part of a recent pattern.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure under Rule 144; transparency is positive but sale size appears immaterial to company control or governance.

The filer follows Rule 144 notice requirements and affirms no undisclosed material adverse information, which supports regulatory compliance and transparent reporting. The sale involves 200,000 shares acquired via a private investment from the issuer on 06/05/2020. The disclosure of broker, sale amount, and acquisition details aligns with expected governance practices for controlled or affiliated holders notifying intended sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	200000	788000	202499045	08/11/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/05/2020	Private investment	Issuer			200000	06/05/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the REAX Form 144 disclose?

The filing reports a proposed sale of 200,000 common shares under Rule 144, with an aggregate market value of $788,000.

When is REAX expected to sell the shares?

The Form 144 lists an approximate date of sale of 08/11/2025.

How were the shares being sold acquired according to the filing?

The securities were acquired on 06/05/2020 in a private investment from the issuer and payment was made in cash.

How many REAX shares are outstanding per this filing?

The filing reports 202,499,045 shares outstanding.

Has the filer sold any REAX securities in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months.